CS
Candriam SCA Portfolio holdings
AUM
$17.3B
This Quarter Return
+8.36%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$3.74B
AUM Growth
+$3.74B
(-8.2%)
Cap. Flow
-$516M
Cap. Flow
% of AUM
-13.8%
Top 10 Holdings %
Top 10 Hldgs %
21.69%
Holding
676
New
53
Increased
217
Reduced
236
Closed
121
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
$118M |
| 2 |
Intel
INTC
|
$62.4M |
| 3 |
Alphabet (Google) Class C
GOOG
|
$26.7M |
| 4 |
Clorox
CLX
|
$25.8M |
| 5 |
TJX Companies
TJX
|
$24.1M |
Top Sells
| 1 |
Amgen
AMGN
|
$107M |
| 2 |
Apple
AAPL
|
$71.8M |
| 3 |
Travelers Companies
TRV
|
$27.6M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$27.4M |
| 5 |
American Express
AXP
|
$26.9M |
Sector Composition
| 1 | Healthcare | 28.7% |
| 2 | Financials | 10.88% |
| 3 | Technology | 9.78% |
| 4 | Communication Services | 9.12% |
| 5 | Consumer Staples | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Alphabet (Google) Class A
GOOGL
$2.57T
| $118M | 3.17% | +152,164 | New | +$118M |
|
2
Gilead Sciences
GILD
$140B
| $118M | 3.15% | 1,163,121 +1,331 | +0.1% | +$135K |
|
|
3
Intel
INTC
$107B
| $93.4M | 2.5% | 2,712,523 +1,811,058 | +201% | +$62.4M |
|
4
Johnson & Johnson
JNJ
$427B
| $84.3M | 2.26% | 820,839 -207,632 | -20% | -$21.3M |
|
|
CELG
5
DELISTED
Celgene Corp
CELG
| $78.9M | 2.11% | 658,700 +9,970 | +2% | +$1.19M |
|
6
Biogen
BIIB
$19.4B
| $74.4M | 1.99% | 243,019 +30,283 | +14% | +$9.28M |
|
7
Procter & Gamble
PG
$368B
| $70.6M | 1.89% | 889,382 +274,886 | +45% | +$21.8M |
|
8
PepsiCo
PEP
$204B
| $69M | 1.85% | 690,741 +27,134 | +4% | +$2.71M |
|
9
Regeneron Pharmaceuticals
REGN
$61.5B
| $52.6M | 1.41% | 96,923 -10,945 | -10% | -$5.94M |
|
10
Exxon Mobil
XOM
$487B
| $51.5M | 1.38% | 660,200 +118,604 | +22% | +$9.25M |
|
11
Nike
NKE
$114B
| $51.2M | 1.37% | 819,242 +384,748 | +89% | +$24M |
|
12
Microsoft
MSFT
$3.77T
| $48.9M | 1.31% | 881,852 +182,195 | +26% | +$10.1M |
|
13
Starbucks
SBUX
$100B
| $48.5M | 1.3% | 807,990 -11,872 | -1% | -$713K |
|
14
Pfizer
PFE
$141B
| $44.1M | 1.18% | 1,367,542 -55,428 | -4% | -$1.79M |
|
15
Visa
V
$683B
| $43.8M | 1.17% | 564,925 -80,354 | -12% | -$6.23M |
|
16
McKesson
MCK
$85.4B
| $39.6M | 1.06% | 200,664 +51,009 | +34% | +$10.1M |
|
|
17
TJX Companies
TJX
$152B
| $38.1M | 1.02% | 537,851 +340,314 | +172% | +$24.1M |
|
18
AT&T
T
$209B
| $38.1M | 1.02% | 1,107,709 -675 | -0.1% | -$23.2K |
|
19
Meta Platforms (Facebook)
META
$1.86T
| $36.6M | 0.98% | 350,098 +167,932 | +92% | +$17.6M |
|
|
20
Clorox
CLX
$14.5B
| $35.4M | 0.95% | 278,918 +203,205 | +268% | +$25.8M |
|
21
Verizon
VZ
$186B
| $35.1M | 0.94% | 759,545 -22,060 | -3% | -$1.02M |
|
22
AbbVie
ABBV
$372B
| $33M | 0.88% | 557,682 -5,881 | -1% | -$348K |
|
23
Vertex Pharmaceuticals
VRTX
$100B
| $30.6M | 0.82% | 243,162 -19,683 | -7% | -$2.48M |
|
24
Estee Lauder
EL
$33B
| $30.3M | 0.81% | 343,726 +199,842 | +139% | +$17.6M |
|
25
Incyte
INCY
$16.5B
| $30.2M | 0.81% | 278,424 -18,960 | -6% | -$2.06M |
|